Publication: Active site binding modes of curcumin in HIV-1 protease and integrase
Issued Date
2005-07-15
Resource Type
ISSN
0960894X
Other identifier(s)
2-s2.0-20644442241
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Bioorganic and Medicinal Chemistry Letters. Vol.15, No.14 (2005), 3364-3368
Suggested Citation
Opa Vajragupta, Preecha Boonchoong, Garrett M. Morris, Arthur J. Olson Active site binding modes of curcumin in HIV-1 protease and integrase. Bioorganic and Medicinal Chemistry Letters. Vol.15, No.14 (2005), 3364-3368. doi:10.1016/j.bmcl.2005.05.032 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/16315
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Active site binding modes of curcumin in HIV-1 protease and integrase
Other Contributor(s)
Abstract
Structure models for the interaction of curcumin with HIV-1 integrase (IN) and protease (PR) were investigated using computational docking. Curcumin was found to bind preferentially in similar ways to the active sites of both IN and PR. For IN, the binding site is formed by residues Asp64, His67, Thr66, Glu92, Thr93, Asp116, Ser119, Asn120, and Lys159. Docked curcumin contacts the catalytic residues adjacent to Asp116 and Asp64, and near the divalent metal (Mg2+). In the PR docking, the curcumin structure fitted well to the active site, interacting with residues Asp25, Asp29, Asp30, Gly27′, Asp29′, and Asp30′. The results suggest that o-hydroxyl and/or keto-enol structures are important for both IN and PR inhibitory actions. The symmetrical structure of curcumin seems to play an important role for binding to the PR protein, whereas the keto-enol and only one side of the terminal o-hydroxyl showed tight binding to the IN active site. © 2005 Elsevier Ltd. All rights reserved.